Effect of obesity on myocardial tissue characteristics in patients with hypertrophic cardiomyopathy: a cardiovascular magnetic resonance-based study

Effect of obesity on myocardial tissue characteristics in patients with hypertrophic cardiomyopathy: a cardiovascular magnetic resonance-based study

Background: Obesity is associated with cardiac steatosis in healthy adults and is independently associated with increased left ventricular (LV) mass and could contribute to the progression of heart failure-related composite events in patients with hypertrophic cardiomyopathy (HCM). However, it is un...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jie Wang, Lutong Pu, Jinquan Zhang, Ruihao Xu, Yang Li, Mengdi Yu, Yangjie Li, Jiajun Guo, Yuanwei Xu, Yu Kang, Yuchi Han, Yucheng Chen
Format:	Article
Language:	English
Published:	Elsevier 2025-01-01
Series:	Journal of Cardiovascular Magnetic Resonance
Subjects:	Hypertrophic cardiomyopathy (HCM) Obesity Cardiovascular magnetic resonance Late gadolinium enhancement T1 mapping
Online Access:	http://www.sciencedirect.com/science/article/pii/S1097664725000651
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Unveiling Clinical and Genetic Distinctions in Pure‐Apical Versus Distal‐Dominant Apical Hypertrophic Cardiomyopathy
by: Kenta Sugiura, et al.
Published: (2025-03-01)

Accelerated myocardial fibrosis in young to middle-aged patients with hypertrophic cardiomyopathy
by: Shiro Nakamori, et al.
Published: (2024-01-01)

Late Gadolinium Enhancement and Electrocardiographic Associations in Hypertrophic Cardiomyopathy
by: Issa Asfour, et al.
Published: (2025-07-01)

Association between cardiac dysfunction and late gadolinium enhancement confined to the LV intramural region in patients with hypertrophic cardiomyopathy
by: Zhi Yang, et al.
Published: (2025-12-01)

Late gadolinium-enhanced cardiovascular magnetic resonance for predicting left ventricular reverse remodeling in dilated cardiomyopathy: A comprehensive review and meta-analysis
by: Yaqiong Zhou, et al.
Published: (2025-01-01)

Role of late gadolinium enhancement in the risk stratification of pediatric hypertrophic cardiomyopathy: based on a Chinese cohortResearch in context
by: Xingrui Chen, et al.
Published: (2025-05-01)

The associations among genetic features, late gadolinium enhancement and prognosis in hypertrophic cardiomyopathy
by: Wenhua Su, et al.
Published: (2025-07-01)

Interplay of ST2 downregulation and inflammatory dysregulation in hypertrophic cardiomyopathy pathogenesis
by: Xingyu Cao, et al.
Published: (2025-06-01)

Myocarditis in Hypertrophic Cardiomyopathy: Incidence and Contribution to Disease Progression and Outcome
by: Yulia Lutokhina, et al.
Published: (2025-04-01)

Evidence of Declining Mortality Trends for Hypertrophic Cardiomyopathy in the United States and the Impact of the COVID‐19 Pandemic
by: Ahmed Sayed, et al.
Published: (2025-04-01)

Phenotype variation of hypertrophic cardiomyopathy in carriers of the p.Arg870His pathogenic variant in the MYH7 gene
by: A. N. Kucher, et al.
Published: (2022-10-01)

Non‐Invasive Diagnosis of Hypertrophic Cardiomyopathy by Breath
by: Yael Hershkovitz‐Pollak, et al.
Published: (2025-07-01)

Evaluating the Role of Multimodal Imaging in the Diagnosis of Cardiac Amyloidosis and Hypertrophic Cardiomyopathy
by: Zi‐xin Yang, et al.
Published: (2025-05-01)

Temporal Patterns of Holter-Detected Arrhythmias in Hypertrophic Cardiomyopathy Patients Treated with Mavacamten
by: Amro Badr, et al.
Published: (2025-04-01)

Features of Diagnostics and Course of Hypertrophic Cardiomyopathy in Real Clinical Practice
by: E. V. Reznik, et al.
Published: (2023-06-01)

Game changer: understanding and managing hypertrophic cardiomyopathy in athletes
by: Maria Kulak, et al.
Published: (2024-09-01)

Cardiac magnetic resonance imaging in arrhythmogenic cardiomyopathy: evolving diagnostic criteria and new capabilities
by: S A. Aleksandrova, et al.
Published: (2024-12-01)

INFECTIVE ENDOCARDITIS IN THE PRESENCE OF HYPERTROPHIC CARDIOMYOPATHY
by: E. Yu. Ponomareva
Published: (2014-07-01)

Myocardial morphology in hypertrophic cardiomyopathy: the current state of the problem
by: A. A. Balabai
Published: (2019-06-01)

Hypertrophic Cardiomyopathy: Genes and Mechanisms
by: Jinli Chen, et al.
Published: (2025-02-01)

Infective Endocarditis in Patients with Hypertrophic Cardiomyopathy
by: E. Yu. Ponomareva, et al.
Published: (2021-09-01)

Disparate Molecular Properties of Two Hypertrophic Cardiomyopathy-Associated cMyBP-C Mutants Reveal Distinct Pathogenic Mechanisms Beyond Haploinsufficiency
by: Angelos Thanassoulas, et al.
Published: (2025-04-01)

Three Novel Pathogenic Variants in Unrelated Vietnamese Patients with Cardiomyopathy
by: Dac Dai Tran, et al.
Published: (2024-11-01)

Sepsis-induced suicidal left ventricular in a patient with hypertrophic cardiomyopathy/hypertrophic obstructive cardiomyopathy
by: K Roshan Rao, et al.
Published: (2022-01-01)

Cardiac Phase-Resolved T<sub>2</sub><sup>*</sup> Magnetic Resonance Imaging Reveals Differences Between Normal Hearts and a Humanized Mouse Model of Hypertrophic Cardiomyopathy
by: Oumaima Laghzali, et al.
Published: (2025-05-01)

Coronary-Cameral Fistula Following Myectomy in Hypertrophic Obstructive Cardiomyopathy
by: Alex Pu, MD, et al.
Published: (2025-06-01)

The Diagnostic Value of Copy Number Variants in Genetic Cardiomyopathies and Channelopathies
by: Valerio Caputo, et al.
Published: (2025-07-01)

Utility of Cardiac Computed Tomography in the Diagnosis of Apical Hypertrophic Cardiomyopathy: A Case Series
by: Dinkar Bhasin, et al.
Published: (2024-10-01)

RARE CASES OF HYPERTROPHIC CARDIOMYOPATHY: VARIANTS AND CLINICAL OBSERVATIONS
by: V. Yu. Zimina, et al.
Published: (2015-09-01)

AMIODARONE THYROTOXICOSIS IN A PATIENT WITH HYPERTROPHIC CARDIOMYOPATHY
by: P. Kh. Dzhanashiya, et al.
Published: (2009-06-01)

Clinical Characteristics and Prognosis of Patients with End-Stage Hypertrophic Cardiomyopathy from a Tertiary Center Cohort: Systolic Dysfunction and Advanced Diastolic Dysfunction
by: Andreea Sorina Afana, et al.
Published: (2025-04-01)

IVABRADIN AND ATENOLOL EFFECTIVENESS COMPARISON IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
by: P. Kh. Dzhanashiya, et al.
Published: (2010-02-01)

INFECTIVE ENDOCARDITIS IN THE PRESENCE OF HYPERTROPHIC CARDIOMYOPATHY: CLINICAL CASES
by: Ye. Yu. Ponomareva, et al.
Published: (2014-11-01)

Myocardial expression of connexin 43 in cats with hypertrophic and restrictive cardiomyopathy phenotype
by: Dmitrij Oleynikov
Published: (2025-03-01)

Hypertrophic Cardiomyopathy with Special Focus on Mavacamten and Its Future in Cardiology
by: Ewelina Młynarska, et al.
Published: (2024-11-01)

Electrocardiographic parameter profiles for differentiating hypertrophic cardiomyopathy stages
by: Naomi Hirota, et al.
Published: (2025-04-01)

Utilization of Cardiac Magnetic Resonance Imaging for Assessing Myocardial Fibrosis in Prognosis Evaluation and Risk Stratification of Patients with Dilated Cardiomyopathy
by: Xin-Yi Feng, et al.
Published: (2025-01-01)

Research Progress of Perioperative Anesthesia Management in Patients with Hypertrophic Cardiomyopathy
by: LIN Shuantong, et al.
Published: (2025-01-01)

MYOCARDIAL REMODELLING TYPES IN HYPERTROPHIC NON-OBSTRUCTIVE CARDIOMYOPATHY
by: D. V. Bogdanov
Published: (2015-05-01)

Effects of genetic mutations on left ventricular myocardial mechanics and fibrosis patterns in hypertrophic cardiomyopathy
by: Minjeong Kim, et al.
Published: (2025-01-01)